Literature DB >> 11196698

Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression.

M Boniotto1, S Crovella, D Pirulli, G Scarlatti, A Spanò, L Vatta, S Zezlina, P A Tovo, E Palomba, A Amoroso.   

Abstract

We investigated the polymorphisms of the promoter region of the MBL2 gene, which codifies for the Mannose-binding protein (MBP). The study population included 90 children with vertically acquired HIV-infection, further divided on the basis of the disease rate, 27 HIV exposed-uninfected children, and 74 healthy control subjects matched for ethnic origin to evaluate the MBP involvement in the risk of HIV-1 infection and to assess the role of the MBP promoter in AIDS progression. A region of 380 bp in the promoter of the MBL2 gene was analysed by PCR and direct sequencing of both DNA strands. We found that the polymorphism at position -550 influences the risk of HIV-infection and AIDS progression. Also a 6 bp deletion at position -328 was correlated with HIV-1 infection. This study indicates that the promoter of the MBL2 gene influences vertical transmission of HIV and the course of perinatal infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11196698     DOI: 10.1038/sj.gene.6363685

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  20 in total

1.  MBL2 variations and malaria susceptibility in Indian populations.

Authors:  Aditya Nath Jha; Pandarisamy Sundaravadivel; Vipin Kumar Singh; Sudhanshu S Pati; Pradeep K Patra; Peter G Kremsner; Thirumalaisamy P Velavan; Lalji Singh; Kumarasamy Thangaraj
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

2.  How does mother-to-child transmission of HIV differ among African populations? Lessons from MBL2 genetic variation in Zimbabweans.

Authors:  Kudakwashe Mhandire; Gavin Pharo; Gwendolene Q Kandawasvika; Kerina Duri; Marelize Swart; Babill Stray-Pedersen; Collet Dandara
Journal:  OMICS       Date:  2014-03-06

3.  Mannose-binding lectin in HIV infection.

Authors:  Sarah Eisen; Agnieszka Dzwonek; Nigel J Klein
Journal:  Future Virol       Date:  2008-05       Impact factor: 1.831

Review 4.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  A whole genome association study of mother-to-child transmission of HIV in Malawi.

Authors:  Bonnie R Joubert; Ethan M Lange; Nora Franceschini; Victor Mwapasa; Kari E North; Steven R Meshnick
Journal:  Genome Med       Date:  2010-03-01       Impact factor: 11.117

6.  MBL2 genetic polymorphisms and HIV-1 mother-to-child transmission in Zambia.

Authors:  Luisa Zupin; Vania Polesello; Ludovica Segat; Louise Kuhn; Sergio Crovella
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

7.  Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations.

Authors:  Gabriel Catano; Brian K Agan; Hemant Kulkarni; Vanessa Telles; Vincent C Marconi; Matthew J Dolan; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2008-07-01       Impact factor: 5.226

8.  An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children.

Authors:  Kumud K Singh; Alexis Lieser; Ping K Ruan; Terry Fenton; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2008-07       Impact factor: 10.793

Review 9.  Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.

Authors:  Gregory A Poland; Richard B Kennedy; Brett A McKinney; Inna G Ovsyannikova; Nathaniel D Lambert; Robert M Jacobson; Ann L Oberg
Journal:  Semin Immunol       Date:  2013-06-05       Impact factor: 11.130

10.  Functional genetic variants in DC-SIGNR are associated with mother-to-child transmission of HIV-1.

Authors:  Geneviève Boily-Larouche; Anne-Laure Iscache; Lynn S Zijenah; Jean H Humphrey; Andrew J Mouland; Brian J Ward; Michel Roger
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.